Approval · Notice of Compliance 19064 · 2017
TARO-TESTOSTERONE: Notice of Compliance 19064
Issued March 14, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19064
- Date
- March 14, 2017
- Company
- Taro Pharmaceuticals IncBrampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the labels
- Canadian reference product
- ANDRIOL (Organon Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARO-TESTOSTERONE | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE UNDECANOATE 40 MG per CAP